Skip to main content
EWTX logo

EWTX · Edgewise Therapeutics, Inc. · Analyst Estimates

Track EWTX — free
$40.30 -1.10 (-2.66%) At close · Oct 5
Market Cap
$4.27B
Shares
108.60M
Volume · Oct 5 1.63M Avg daily vol (3M) 1.35M

Analyst Estimates

Compare analyst forecasts for Edgewise Therapeutics, Inc. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-09-22 12:48 UTC · Publication dates shown per estimate · 16 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-2.42
1.38027
10.28
—
1.38027
-0.23431
1.38027
-0.23431
— — — —
EPS
analysts
Publication date not stated
— — —
10
— — — —
5
1
0
0
Revenue
USD
Publication date not stated
0
139583330
1675000000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
12
— — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-3.44
-1.81614
-0.47
—
-1.81614
-1.4729
-1.81614
-1.42474
— — — —
EPS
analysts
Publication date not stated
— — —
11
— — — —
6
1
1
0
Revenue
USD
Publication date not stated
0
42727270
200000000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
11
— — — — — — — —

Q ending 2026-09-30

Analyst estimates for Q ending 2026-09-30
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.64
2.80744
11.45
—
2.80744
1.1328
2.80744
1.1328
— — — —
EPS
analysts
Publication date not stated
— — —
10
— — — —
4
1
1
0
Revenue
USD
Publication date not stated
0
129166670
1550000000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
12
— — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.78
-0.38262
0.6
—
-0.38262
-0.31281
-0.38262
-0.31219
— — — —
EPS
analysts
Publication date not stated
— — —
12
— — — —
5
1
2
0
Revenue
USD
Publication date not stated
0
10416670
125000000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
12
— — — — — — — —
Key facts CIK 1710072 CUSIP 28036F105 13F (30d) 6 filings 6 filers Visit website Investor relations